Anti-glatiramer acetate antibody levels in treated multiple sclerosis patients

被引：0
|
作者：
Oger, J [1 ]
Gibb, E [1 ]
Basile, E [1 ]
Aziz, T [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷 / 01期
关键词：
enzyme linked immunosorbent assay; ELISA; glatiramer acetate (GA); immunoglobulin G; IgG; optical density; OD; peripheral blood mononuclear cells; PBMC; pokeweed mitogen; PWM;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [31] A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate
    Moreau, T.
    Brudon, F.
    Debouverie, M.
    Heinzlef, O.
    Lebrun-Frenay, C.
    Gury, C.
    MULTIPLE SCLEROSIS, 2006, 12 : S99 - S99
  • [32] microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate
    Dominguez-Mozo, Maria I.
    Casanova, Ignacio
    De Torres, Laura
    Aladro-Benito, Yolanda
    Perez-Perez, Silvia
    Garcia-Martinez, Angel
    Gomez, Patricia
    Abellan, Sara
    De Antonio, Esther
    Lopez-De-Silanes, Carlos
    Alvarez-Lafuente, Roberto
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] Evidence for use of glatiramer acetate in multiple sclerosis
    Caramanos, Z
    Arnold, DL
    LANCET NEUROLOGY, 2005, 4 (02): : 74 - 75
  • [34] Monitoring Glatiramer Acetate treatment in multiple sclerosis
    Farina, C
    Hohlfeld, R
    NEUROLOGY, 2002, 58 (07) : A246 - A246
  • [35] The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment
    Messina, Silvia
    Patti, Francesco
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (10) : 1349 - 1359
  • [36] Assessment of quality of life with the subjective quality of life profile in multiple sclerosis patients treated with glatiramer acetate
    Moreau, T.
    Chassany, O.
    Montreuil, M.
    Sanchez-Ponton, A.
    Criquet, A.
    Allouche, S.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S265 - S265
  • [37] Economic impact of glatiramer acetate in multiple sclerosis
    Ollendorf, DA
    Jilinskaia, E
    Oleen-Burkey, M
    VALUE IN HEALTH, 2002, 5 (06) : 510 - 511
  • [38] Glatiramer acetate therapy for multiple sclerosis: a review
    Perumal, Jai
    Filippi, Massimo
    Ford, Corey
    Johnson, Kenneth
    Lisak, Robert
    Metz, Luanne
    Tselis, Alexandros
    Tullman, Mark
    Khan, Omar
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) : 1019 - 1029
  • [39] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Schrempf, Wiebke
    Ziemssen, Tjalf
    AUTOIMMUNITY REVIEWS, 2007, 6 (07) : 469 - 475
  • [40] Mechanisms of action of glatiramer acetate in multiple sclerosis
    Neuhaus, O
    Farina, C
    Wekerle, H
    Hohlfeld, R
    NEUROLOGY, 2001, 56 (06) : 702 - 708
12345